あなたはまだ TradeKey.com のメンバーではないようです。 今すぐサインアップして、世界中で700万を超える輸入業者および輸出業者と接続します。
今すぐ加入、無料 |
BOOK A CALL
Book Call On Your Favorite Time

By Signing Up. I agree to TradeKey.com Terms of Use, Privacy Policy, IPR and receive emails related to our services

Contact Us
Pirfenidone
Prev
Pirfenidone
Next

Pirfenidone

离岸价格

Get Latest Price

|

- Minimum Order

国:

China

モデル番号:

Pirfenidone (INN, BAN)

离岸价格:

Get Latest Price

ロケーション:

-

最低注文量の価格:

-

最低注文量:

-

パッケージの詳細:

-

納期:

-

供給能力:

-

支払いタイプ:

-

製品グループ :

-

今すぐお問い合わせください
無料会員

連絡先担当者 lansky

nanhu road, Wuhan, Hubei

今すぐお問い合わせください

製品仕様

  • Other Names: Pirfenidone (INN, BAN)
  • Type : Central Nervous System Agents
  • Grade Standard: Cosmetic Grade
  • Brand Name: vanz
  • Purity (%): 98
  • white:powder

タイトルまたは説明

Pirfenidone (INN, BAN) is a drug developed by several companies worldwide, including InterMune Inc. (now part of Roche), Shionogi Ltd., and GNI Group Ltd., for the treatment of idiopathic pulmonary fibrosis (IPF). In ***8, it was first approved in Japan for the treatment of IPF after clinical trials, under the trade name of Pirespa by Shionogi & Co. In October ***0, the Indian Company Cipla launched it as Pirfenex. In ***1, it was approved for use in Europe for IPF under the trade name Esbriet,[2] and was approved in the United States in October ***4 under the same name. In September ***1, the Chinese State Food and Drug Administration provided GNI Group Ltd with new drug approval of pirfenidone in China,[3] and later manufacture approval in ***3 under the trade name of Etuary.[4]

In ***4 it was approved in Mxico under the name KitosCell LP, indicated for pulmonary fibrosis and liver fibrosis.[5] There is also a topical form created for the treatment of abnormal wound healing processes

国: China
モデル番号: Pirfenidone (INN, BAN)
离岸价格: Get Latest Price
ロケーション: -
最低注文量の価格: -
最低注文量: -
パッケージの詳細: -
納期: -
供給能力: -
支払いタイプ: -
製品グループ : -

関連製品 wuhan vanz pharm Inc.

Send a direct inquiry to this supplier

To:

lansky < wuhan vanz pharm Inc. >

私は知りたい: